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Abstract
Background The aim of life-support measures in brain-dead
donors is to preserve the functional value of their organs. In renal
transplantation, serum creatinine level is one of the criteria for
graft harvest. The aim of this study was to assess the impact of
intensive care on donor renal function through two criteria:
preharvesting serum creatinine level above 120 μmol/L and the
elevation of serum creatinine level above 20% between
intensive care unit (ICU) admission and graft harvest.
Methods Between 1 January 1999 and 31 December 2005, we
performed an observational study on 143 brain-dead donors.
ICU chronology, hemodynamic, hematosis, and treatment data
were collected for each patient from ICU admission to kidney
removal.
Results Twenty-two percent of the 143 patients had a serum
creatinine level above 120 μmol/L before graft harvest. The
independent factors revealed by multivariate analysis were the
administration of epinephrine (odds ratio [OR]: 4.36, 95%
confidence interval [CI]: 1.33 to 14.32; p = 0.015), oliguria (OR:
3.73, 95% CI: 1.22 to 11.36; p = 0.021), acidosis (OR: 3.26,
95% CI: 1.07 to 9.95; p = 0.038), the occurrence of
disseminated intravascular coagulation (OR: 3.97, 95% CI:
1.05 to 15.02; p = 0.042), female gender (OR: 0.13, 95% CI:
0.03 to 0.50; p = 0.003), and the administration of
desmopressin (OR: 0.12, 95% CI: 0.03 to 0.44; p = 0.002). The
incidence of elevated serum creatinine level above 20%
between admission and graft harvest was 41%. The
independent risk factors were the duration of brain death greater
than 24 hours (OR: 2.64, 95% CI: 1.25 to 5.59; p = 0.011) and
the volume of mannitol (OR: 2.08, 95% CI: 1.03 to 4.21; p =
0.041).
Conclusion This study shows that the resuscitation of brain-
dead donors impacts on their renal function. The uses of
epinephrine and mannitol are associated with impairment of
kidney function. It seems that graft harvest should be performed
less than 24 hours after brain death diagnosis.
Introduction
The success of organ transplantation depends on the quality
of the resuscitation of donors [1]. However, its renal impact
has not been subject to much evaluation up to the present. To
the best of our knowledge, no studies have evaluated the
impact of the resuscitation on the preharvesting renal function
of potential brain-dead donors. The risk factors for renal func-
tion impairment in such patients are important since this can
affect the future renal graft. Consequently, the primary objec-
tive of the present study was to assess the risk factors for renal
impairment defined by a serum creatinine level above 120
μmol/L in a cohort of brain-dead donors. The secondary objec-
tive was to evaluate the risk factors for renal function deterio-
ration, which was defined by a more than 20% rise of serum
creatinine levels between intensive care unit (ICU) admission
and graft harvest.Page 1 of 9
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Between 1 January 1999 and 31 December 2005, a retro-
spective observational study was conducted on 143 of 150
brain-dead donors admitted to a 16-bed medico-surgical ICU
of an 800-bed university hospital (Hôpital Nord, Marseille,
France) (Figure 1). Informed consent and approval by the eth-
ics committee were waived due to observational nature of the
study.
Computer data were collected prospectively by the physicians
upon admission and during ICU stay. Physicians met weekly to
complete the data after discharge. During data extraction, a
software program performed a final check by eliminating aber-
rant values and suppressing duplications. The rate of uncom-
pleted files was 5% (missing data: >5%). Patients with
uncompleted files were excluded from the study. When the
rate of missing data was less than 5%, they were ignored.
Donor resuscitation was performed according to standard
clinical practices. Diagnosis of brain death was confirmed by
the presence of a profound coma (flaccid, hypotonic, areac-
tive) with no cerebral trunk reflex and the absence of ventila-
tory movement in a hypercapnic patient (PaCO2 [arterial partial
pressure of carbon dioxide] of greater than 60 mm Hg) [2]. In
accordance with French legislation, clinical diagnosis was
confirmed by two electroencephalograms performed at least 4
hours apart or by angiography. As soon as the clinical diagno-
sis of brain death was confirmed, donor intensive care was
performed according to French Society of Anesthesia and
Intensive Care guidelines [3]. A written protocol, which is
extracted from these guidelines, was distributed to all medical
staff of our ICU.
Serum creatinine level is the most universal biological marker
for estimating the glomerular filtration with a good prognostic
value. Preharvesting serum creatinine level is considered to be
an important determinant of renal function after transplantation
[4]. Hence, the present study evaluated the impact of the
resuscitation of brain-dead donors on renal function. The pri-
mary objective was to assess the risk factors associated with
a preharvesting serum creatinine level above 120 μmol/L. To
better characterize the impact of care provided in the ICU, the
secondary objective was to identify the risk factors associated
with a rise of more than 20% in serum creatinine levels
between ICU admission and graft harvest. These two criteria
have been reported in an article analyzing preoperative risk
factors for acute postoperative renal failure [5,6]. The present
study evaluated the influence of these two criteria on the renal
graft quality through four criteria: delayed graft function, early
acute rejection, return in dialysis (1 month, 1 year), and mortal-
ity (1 year). Delayed graft function was defined by the need for
dialysis in the 7 days after transplantation [7]. Acute rejection
of the renal allograft was defined by an elevation of serum cre-
atinine levels of more than 20% between two successive
measurements confirmed by a second biological screening
and after elimination of another cause of graft dysfunction,
which could be functional, toxic, urologic, or vascular. Any sus-
picion of acute rejection was confirmed by a histologic exami-
nation [8]. Data from donors were analyzed from ICU
admission to kidney harvest. The demographic (gender and
age) data, causes of ICU admission, duration of ICU stay,
duration of shock, duration of brain death (from the clinical
diagnosis), drugs used during the ICU stay (fluid expansion,
catecholamines, osmotherapy, diuretics, and desmopressin),
hemodynamic profile during ICU resuscitation, characteristics
of renal function on admission and during ICU stay with spe-
cial interest in oliguria (defined by a urine output of less than
0.5 mL/kg per hour for at least 2 consecutive hours), and cre-
atinine serum levels were collected. Catecholamines have
been used alone or in combination, as required, according to
the attending physician.
Figure 1
Flow chart of the inclusion.Page 2 of 9
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Available online http://ccforum.com/content/11/5/R103Biological disseminated intravascular coagulation is defined
by elevated D-dimers (D-dimers greater than 500 μg/L) and
one major criterion for consumption of platelets or coagulation
factors (platelet count of less than 50,000 mm-3 or
international normalized ratio of the prothrombin time of
greater than 1.5) or two minor criteria for consumption of
platelets or coagulation factors (platelet count of between
50,000 and 100,000 mm-3 and international normalized ratio
of the prothrombin time of between 1.2 and 1.5) [9]. Shock
was defined by hypotension (systolic blood pressure of less
than 90 mm Hg or a mean arterial pressure of less than 65 mm
Hg) not reversed with fluid resuscitation and serum lactate
level of above 3 mmol/L [10].
The collected data were entered into a Microsoft® Office Excel
2000 spreadsheet (Microsoft Corporation, Redmond, WA,
USA) and then were transferred to SPSS version 11.5.1.®
software (SPSS Inc., Chicago, IL, USA) for analysis of the
results. Quantitative variables are presented in the form of
mean ± standard deviation. Qualitative variables are
expressed as percentages. For the univariate analysis, we
determined the associations between serum creatinine level
above 120 μmol/L or a rise of more than 20% in serum creat-
inine levels between ICU admission and organ harvest. The
quantitative variables were assessed by a Student's t test or
an analysis of variance. For the qualitative variables, a chi-
square test or a Fisher exact test were used. For the multivari-
ate analysis, the variables provided by univariate analysis were
put into a logistic regression model. The values of successive
models were evaluated by the Hosmer and Lemeshow test.
The threshold for significance of the statistical tests was set at
5%.
Results
Demographic characteristics and parameters of resuscitation
are shown in Table 1. The age of patients was 38 ± 14 years.
Males represented 62% of the study population. Head trauma
(49%) and spontaneous intracranial bleeding (40%)
accounted for the most frequent causes of death. Among
these 143 donors, 31 (22%) had a serum creatinine concen-
tration above 120 μmol/L. The significant risk factors associ-
ated with preharvesting serum creatinine level above 120
μmol/L are summarized in Table 1. The occurrence of dissem-
inated intravascular coagulation and the occurrence of cardiac
arrest, shock, or acidosis were statistically associated with a
serum creatinine level above 120 μmol/L. For catecholamines,
the use of epinephrine was associated with a serum creatinine
level above 120 μmol/L. Substitutive opotherapy by desmo-
pressin had no adverse effect on renal function. As shown in
Table 2, six independent risk factors were retained by the
logistic regression model (Hosmer-Lemeshow statistic: 0.96,
with 85.3% of patients correctly identified by the model). The
use of epinephrine during the donor resuscitation and the
occurrence of oliguria, acidosis, and disseminated intravascu-
lar coagulation were significantly associated with a preharvest-
ing serum creatinine level above 120 μmol/L. On the other
hand, the administration of desmopressin and female gender
were negatively correlated with a preharvesting serum creati-
nine level above 120 μmol/L. The rate of delayed graft function
was significantly increased in the recipients from the donors
with a serum creatinine level above 120 μmol/L as compared
with those from donors with a serum creatinine level below
120 μmol/L. By contrast, there were no differences in the rates
of acute rejection, return to dialysis, and mortality (Table 3).
A rise of more than 20% in serum creatinine levels between
ICU admission and graft harvest was observed in 58 (41%)
patients (Table 4). This rise was detected in the patients who
were treated with a large volume of mannitol (276 ± 241 mL
versus 123 ± 221 mL; p = 0.003), in whom the duration of
brain death was above 24 hours (76% versus 53%; p =
0.006) and in whom an iodinated radiographic contrast was
injected (78% versus 61%; p = 0.04). When multivariate
logistic regression analysis was applied (Hosmer-Lemeshow
statistic: 0.95, with 64.1% of the patients correctly identified
by the model), the volume of mannitol infused during the initial
resuscitation (odds ratio [OR]: 2.08, 95% confidence interval
[CI]: 1.03 to 4.21; p = 0.04) and duration of brain death
greater than 24 hours (OR: 2.64, 95% CI: 1.25 to 5.59; p =
0.01) were associated with a rise of more than 20% in serum
creatinine concentrations. The rise of more than 20% in serum
creatinine levels was not associated with significant changes
in the rates of delayed graft function, acute rejection, return to
dialysis, and mortality (Table 3).
Discussion
To the best of our knowledge, no studies have compared the
impact of resuscitation on renal function before graft harvest.
Brain death is associated with complex hemodynamic, endo-
crine, and metabolic dysfunction that can lead to major com-
plications with the potential donor. Untreated, this can
progress to cardiovascular collapse with loss of valuable
organs for transplantation. However, drugs used have an
adverse potential effect on preharvesting renal function.
The present study confirms that elevated preharvesting serum
creatinine levels are associated with an increased rate of
delayed graft function [11]. Hence, we sought to determine
the factors associated with serum creatinine levels above 120
μmol/L in the donors. The administration of epinephrine is an
independent risk factor associated with a rise in serum creati-
nine level above 120 μmol/L. This risk factor has not been pre-
viously described. The use of epinephrine induces a renal
vasoconstriction [12]. This can also reflect a profound state of
hemodynamic instability. In agreement with our result, a recent
study showed that the use of epinephrine in donors was
associated with a negative influence on the graft quality after
transplantation [13].Page 3 of 9
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Women, number (percentage) 54 (38) 50 (45) 4 (13)a
Age (years) (mean ± SD) 38 ± 14 38 ± 13 39 ± 15
Causes of ICU admission
Head trauma, number (percentage) 70 (49) 50 (45) 20 (65)a
Intracranial bleeding, number (percentage) 57 (40) 53 (47) 4 (13)a
Cerebral anoxia, number (percentage) 8 (5.5) 4 (3.5) 4 (13)
Suicide, number (percentage) 8 (5.5) 5 (4.5) 3 (10)
ICU steps
Duration of stay in ICU (hours) (mean ± SD) 70 ± 64 76 ± 66 49 ± 48a
Duration of brain death (hours) (mean ± SD) 30 ± 14 29 ± 12 33 ± 18
Duration of brain death >24 hours (percentage) 58 (41) 50 (44) 8 (26)
Catecholamines
Dopamine, number (percentage) 37 (26) 32 (29) 5 (16)
Dobutamine, number (percentage) 11 (8) 10 (9) 1 (3)
Epinephrine, number (percentage) 51 (36) 31 (28) 20 (64)a
Norepinephrine, number (percentage) 101 (71) 80 (71) 21 (68)
Fluid expansion
Isotonic saline solution (mL) (mean ± SD) 3,655 ± 4,003 3,667 ± 4,247 3,612 ± 3,015
Lactate ringer (mL) (mean ± SD) 2,582 ± 2,598 2,665 ± 2,633 2,280 ± 2,483
Gelatin (mL) (mean ± SD) 446 ± 928 466 ± 971 370 ± 763
Hydroxyethylstarch, number (percentage) 113 (79) 86 (77) 27 (87)
Hydroxyethylstarch (mL) (mean ± SD) 1,170 ± 1,080 1,140 ± 1,100 1,274 ± 1,015Page 4 of 9
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Mannitol 20% (mL) (mean ± SD) 185 ± 285 200 ± 301 132 ± 215
Hypertonic saline solution 7.5% (mL) (mean ± SD) 131 ± 296 130 ± 281 130 ± 351
Urine output modulators
Furosemide, number (percentage) 36 (25) 30 (27) 6 (19)
Furosemide (mg) (mean ± SD) 16 ± 51 16 ± 56 12 ± 28
Desmopressin, number (percentage) 114 (80) 98 (87) 16 (52)a
Desmopressin (μg) (mean ± SD) 5.9 ± 5.7 6.8 ± 6.1 2.7 ± 3a
Hemodynamic profile during ICU resuscitation
Cardiac arrest, number (percentage) 26 (18) 14 (12) 12 (39)a
Shock, number (percentage) 93 (65) 67 (60) 26 (83)a
Duration of shock (minutes) (mean ± SD) 80 ± 142 61 ± 104 150 ± 223a
MAP upon admission (mm Hg) (mean ± SD) 89 ± 25 93 ± 23 75 ± 26a
Preharvesting MAP (mm Hg) (mean ± SD) 81 ± 17 82 ± 18 77 ± 16
Respiratory profile during ICU resuscitation
Acute respiratory distress syndrome, number (percentage) 53 (37) 37 (33) 16 (52)
Acute lung injury, number (percentage) 33 (23) 30 (27) 3 (10)a
Characteristics of renal function
Oliguria, number (percentage) 66 (46) 44 (39) 22 (71)a
Serum creatinine upon admission (μmol/L) (mean ± SD) 89 ± 38 79 ± 26 125 ± 49a
Preharvesting serum creatinine (μmol/L) (mean ± SD) 98 ± 61 75 ± 21 180 ± 83a
Acidosis (pH <7.30), number (percentage) 45 (31) 24 (21) 21 (68)a
Disseminated intravascular coagulation, number (percentage) 24 (17) 13 (12) 11 (35)a
Injection of contrast, number (percentage) 97 (68) 77 (69) 20 (64)
ap < 0.05. ICU, intensive care unit; MAP, mean arterial pressure; SD, standard deviation.
Table 1 (Continued)
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an independent risk factor associated with a serum creatinine
level above 120 μmol/L. The link between hemostasis and
brain injury has been reported elsewhere [14]. In cases of
cerebral injury, one can observe coagulation disorders result-
ing in disseminated intravascular coagulation [15]. Also, the
occurrence of acidosis is an independent risk factor, probably
reflecting a cellular dysoxia.
The occurrence of oliguria is an independent risk factor asso-
ciated with a serum creatinine concentration above 120 μmol/
L. Oliguria can be a marker of hemodynamic instability or acute
renal failure. This risk factor has been described in recipients
but not in donors [16]. Oliguria, whatever its significance,
should be avoided in potential donors. However, in our study,
the volume of fluid resuscitation did not impact on the value of
preharvesting serum creatinine level. This suggests that an
aggressive volume resuscitation in order to avoid oliguria is not
always associated with clinical success.
Administration of desmopressin was inversely correlated with
the occurrence of a serum creatinine level above 120 μmol/L.
The effects of desmopressin on graft function are variable, and
several studies have reported no changes in renal function
[17]. By contrast, the impact on pancreas grafts is deleterious,
with microthromboses and loss of function [18]. One possible
protective mechanism at the renal level ay be a vasodilatation
obtained via the activation of V2 receptors. Indeed, desmo-
pressin induces a vasodilatation via the production of nitric
oxide [19].
Although the admission serum creatinine levels are signifi-
cantly higher in the group with a preharvesting serum creati-
nine level above 120 μmol/L, this factor is not found as an
independent risk factor. By contrast, the lower preharvesting
serum creatinine level in females can be the consequence of
their lower muscle mass. The analysis of estimated glomerular
filtration rate instead of serum creatinine levels would resolve
this ambiguity.
A rise of more than 20% in serum creatinine levels between
ICU admission and graft harvest, with an incidence of 41%, is
associated with a duration of brain death of greater than 24
hours. A prior study found that the duration of resuscitation
does not influence the quality of kidney grafts transplanted if
the hemodynamic condition of the donor is maintained [20].
However, the link between the quality of kidney graft and the
ICU length of stay appears to be complex. Prolonged ICU stay
of the donor has been shown to be correlated with a lower risk
of delayed graft function in the recipients [13]. In regard to our
results, a long duration of ICU stay before the occurrence of
brain death does not affect the quality of kidney, whereas a
Table 2
Independent risk factors for preharvesting serum creatinine level greater than 120 μmol/L
P value Odds ratio 95% confidence interval
Epinephrine use 0.015 4.36 1.33–14.32
Disseminated intravascular coagulation 0.042 3.97 1.05–15.02
Oliguria 0.021 3.73 1.22–11.35
Acidosis 0.038 3.26 1.07–9.95
Female gender 0.003 0.13 0.03–0.50
Desmopressin use 0.002 0.12 0.03–0.44
Table 3









Delayed graft function, number (percentage) 88 (38) 29 (57)a 35 (37)
Acute rejection, number (percentage) 36 (15.5) 9 (8) 19 (20)
Return in dialysis at 1 month, number (percentage) 8 (3.4) 2 (4) 2 (2.1)
Return in dialysis at 1 year, number (percentage) 14 (6) 3 (6) 4 (4.3)
Mortality at 1 year, number (percentage) 6 (2.6) 4 (7.8) 2 (2.1)
ap < 0.05.Page 6 of 9
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Women, number (percentage) 36 (42) 18 (31)
Age (years) (mean ± SD) 39 ± 14 38 ± 13
Causes of ICU admission
Head trauma, number (percentage) 37 (43) 33 (57)
Intracranial bleeding, number (percentage) 37 (44) 20 (36)
Cerebral anoxia, number (percentage) 6 (8) 2 (3)
Suicide, number (percentage) 5 (6) 3 (5)
ICU steps
Duration of stay in ICU (hours) (mean ± SD) 63 ± 56 80 ± 72
Duration of brain death (hours) (mean ± SD) 27 ± 11 34 ± 17a
Duration of brain death >24 hours, number (percentage) 45 (53) 44 (76)a
Catecholamines
Dopamine, number (percentage) 26 (31) 11 (19)
Dobutamine, number (percentage) 5 (6) 6 (10)
Epinephrine, number (percentage) 28 (33) 23 (40)
Norepinephrine, number (percentage) 58 (68) 43 (74)
Fluid expansion
Isotonic saline solution (mL) (mean ± SD) 3,406 ± 3,825 4,020 ± 4,259
Lactate ringer (mL) (mean ± SD) 2,696 ± 2,641 2,413 ± 2,546
Gelatin (mL) (mean ± SD) 441 ± 930 452 ± 933
Hydroxyethylstarch, number (percentage) 67 (79) 46 (79)
Hydroxyethylstarch (mL) (mean ± SD) 1,047 ± 1,019 1,349 ± 1,148
Osmotherapy
Mannitol 20% (mL) (mean ± SD) 123 ± 221 276 ± 241a
Hypertonic saline solution 7.5% (mL) (mean ± SD) 111 ± 235 159 ± 369
Urine output modulators
Furosemide, number (percentage) 19 (22) 17 (29)
Furosemide (mg) (mean ± SD) 14 ± 57 17 ± 42
Desmopressin, number (percentage) 68 (80) 46 (79)
Desmopressin (μg) (mean ± SD) 5.7 ± 6.2 6.2 ± 5.1
Hemodynamic profile
Cardiac arrest, number (percentage) 16 (19) 10 (17)
Shock, number (percentage) 53 (62) 40 (69)
Duration of shock (minutes) (mean ± SD) 65 ± 108 102 ± 180
MAP upon admission (mm Hg) (mean ± SD) 91 ± 25 87 ± 25
Preharvesting MAP (mm Hg) (mean ± SD) 81 ± 17 81 ± 18Page 7 of 9
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ing renal function. Hence, the duration of brain death should
be shortened as much as possible in order to preserve the
renal function.
This rise is also associated with the use of a large volume of
mannitol. Mannitol increases urine output but does not reduce
the incidence of acute renal failure [21]. Cases of acute renal
failure can be encountered in relation to mannitol serum levels
that are too high [22,23]. One hypothesis is that mannitol infu-
sion could generate osmotic nephrosis-like lesions with a
direct nephrotoxic effect [24]. Interestingly, the use of hyper-
tonic saline solution, which is an alternative to mannitol [25], is
not associated with a worsening of renal function in our
patients.
We acknowledge that the present study has several limita-
tions. The retrospective design limits the interpretation of data.
In addition, the patients were hospitalized in a single institu-
tion, which reflects a local policy of management of donors.
Lastly, to define the worsening of renal function, we used a cri-
terion that is not precisely described in the literature in the field
of renal transplantation. In fact, the definition of acute renal fail-
ure is far from consensus [26]. One can note that our criteria
for evaluating renal function are restrictive.
Conclusion
In summary, within the limitations of this study, the use of
epinephrine in the potential donors is associated with an
increased risk (by a factor of 4.3) of preharvesting serum cre-
atinine level above 120 μmol/L. A large volume of mannitol is
associated with an increased risk (by a factor of 2) of a rise of
more than 20% in serum creatinine levels between ICU admis-
sion and graft harvest, whereas the use of hypertonic saline
solutions does not share this negative effect. Importantly,
although the duration of ICU stay prior to brain death occur-
rence has no impact on the preharvesting renal function, the
transplantation procedure should be performed as soon as the
brain death is detected. Lastly, administration of desmopressin
is associated with a preservation of renal function. This result
deserves to be investigated in further prospective studies.
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Respiratory profile
Acute respiratory distress syndrome, number (percentage) 22 (26) 23 (40)
Acute lung injury, number (percentage) 21 (25) 11 (19)
Characteristics of renal function
Oliguria, number (percentage) 39 (46) 27 (47)
Serum creatinine upon admission (μmol/L) (mean ± SD) 95 ± 42 80 ± 28a
Preharvesting serum creatinine (μmol/L) (mean ± SD) 82 ± 40 121 ± 76a
Acidosis (pH <7.30), number (percentage) 23 (27) 22 (38)
Disseminated intravascular coagulation, number (percentage) 11 (13) 13 (22)
Injection of contrast, number (percentage) 52 (61) 45 (78)a
ap < 0.05. ICU, intensive care unit; MAP, mean arterial pressure; SD, standard deviation.
Table 4 (Continued)
Factors for an elevation of serum creatinine levels of 20% or more
Key messages
• The present study was aimed at assessing the impact of 
intensive care on donor renal function.
• The use of epinephrine in the potential donors is associ-
ated with an increased risk (by a factor of 4.3) of a pre-
harvesting serum creatinine level above 120 μmol/L.
• A large volume of mannitol is associated with a twofold 
risk of a rise of more than 20% in serum creatinine lev-
els between ICU admission and graft harvest, whereas 
the use of hypertonic saline solutions does not share 
this effect.
• Although the duration of ICU stay prior to brain death 
occurrence has no impact on the preharvesting renal 
function, the transplantation procedure should be per-
formed as soon as the brain death is detected. Adminis-
tration of desmopressin is associated with a 
preservation of renal function.Page 8 of 9
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